ALSO NOTED: J&J recalls balloon catheters; Dr. Reddy's stock tanks on loss;

> Johnson & Johnson is recalling 132,000 balloon catheters used to expand blood vessels after it determined that problems with them could cause injury or death; there have been no reported deaths, however. Report

> Dr. Reddy's stock took a tumble in India after the company reported an unexpected $21.5 million loss on declining revenues in the most recent quarter. Report

> Kidnapped January 18, Nicholas Piramal executive Ashwini Bhatt was rescued by a special police task force on Saturday, and the gangs responsible have been identified. Report

> Consumer advocates are asking the FDA to pin more stringent warnings on the wrinkle-fighting drug Botox, citing "serious adverse reactions, including death." Report

> GlaxoSmithKline is the first of the UK's top companies to offer its employees the chance to invest their own pension funds. Report

> Glenmark Pharma got the FDA's clearance for its manufacturing plant in Baddi, India, which makes semi-solid products. Report

> Sanofi-Aventis announced that Japanese regulators cleared its clot-prevention drug Clexane. Report

And Finally... Too much coffee may worsen diabetes, according to a new study in Diabetes Care. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.